The Inducement Grant was granted pursuant to Aligos' 2024 Inducement Plan (the "Plan”) as an inducement material to this ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on March 10, 2025, the Compensation Committee of the ...
The above-described award was made under Biomea’s 2023 Inducement Equity Plan (the “Plan”). The above-described award was granted as an inducement material to the employee entering into ...
The company granted stock options to purchase an aggregate of 157,150 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 107,500 shares of Nurix common ...
Biomea Fusion (BMEA) announced that on March 3, 2025, the compensation committee of Biomea’s board of directors granted one new employee ...
2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with ...
The above-described award was granted as an inducement material to the employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635 (c) (4) and was granted pursuant ...
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to seven newly appointed non-executive employees.
(NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced its entry into a warrant inducement ...
These grants were made under the company's 2023 Employment Inducement Incentive Award Plan (2023 Inducement Plan) as an inducement for employment, in accordance with Nasdaq Listing Rule 5635(c)(4).
The New-Hire Inducement Grants have an exercise price per share that is equal to the closing price of Viridian’s common stock on March 3, 2025. The New-Hire Inducement Grants will vest over a ...